Light-enhanced VEGF121/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatmentAne Sager Longva(Oslo University Hospital), Anette Weyergang(Oslo University Hospital)Frontiers in ImmunologyDecember 19, 202310.3389/fimmu.2023.1278000Cited by 7SaveCiteExport RISWatch citationsRelated PapersRAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer|medRxiv|2021|1